Woo Chul Noh - Concepedia

Author

Woo Chul Noh

Korea Institute of Radiological and Medical Sciences ORCID

Also Known As

Hyeong-Gon Moon, W C Noh, W. Noh, W.C. Noh, WOO CHUL NOH, Woo C. Noh, Woo Chul Noh, Woo Noh

129

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Korea Institute of Radiological and Medical Sciences Yonsei University Asan Medical Center University of Ulsan Sungkyunkwan University

About

Woo Chul Noh is an author at Korea Institute of Radiological and Medical Sciences specializing in medicine, breast cancer, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	764
2	Health Sciences	4	4	96
3	Public Health	3	3	58
4	Engineering	2	2	56
5	Nursing	1	1	68

Woo Chul Noh

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning Joon Ho Choi, Hyun‐Ah Kim, Wook Kim, Scientific Reports	2020	89
Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial Hyun‐Ah Kim, Jong Won Lee, Seok Jin Nam, Journal of Clinical Oncology	2019	88
Prognostic Significance of Young Age (<35 Years) by Subtype Based on ER, PR, and HER2 Status in Breast Cancer: A Nationwide Registry‐Based Study Eun‐Kyu Kim, Woo Chul Noh, Wonshik Han, World Journal of Surgery	2011	74
Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status Hee Jeong Kim, Mi‐Jung Kim, Sei Hyun Ahn, The Breast	2010	74
Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables Woo Chul Noh, Yang Hee Kim, Min Suk Kim, Breast Cancer Research and Treatment Breast OncologySignal TransductionSignaling PathwayBreast CancerClinicopathologic Variables	2007	74
Association of depression and anxiety disorder with the risk of mortality in breast cancer: A National Health Insurance Service study in Korea Eun‐Jung Shim, Jong Won Lee, Jihyoung Cho, Breast Cancer Research and Treatment NursingPsychological Co-morbiditiesPsychiatryMood SymptomEpidemiology Of Cancer	2019	68
STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers Jae‐Sung Kim, Hyun‐Ah Kim, Min-Ki Seong, Oncotarget Breast OncologyCancer BiologyTumor BiologyRadiation MedicineOncology	2016	67
Melatonin enhances arsenic trioxide-induced cell death via sustained upregulation of Redd1 expression in breast cancer cells Sun-Mi Yun, Sang Hyeok Woo, Sang Taek Oh, Molecular and Cellular Endocrinology ApoptosisCell DeathCancer BiologyTumor BiologyOxidative Stress	2015	65
Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer Hee Jeong Kim, Woo Chul Noh, Kyu Eun Lee, Breast Cancer Research	2020	59
Phosphorylated S6K1 is a possible marker for endocrine therapy resistance in hormone receptor-positive breast cancer Eun‐Kyu Kim, Hyun‐Ah Kim, Jae Soo Koh, Breast Cancer Research and Treatment Breast OncologyEndocrine Therapy ResistancePossible MarkerHormonal ReceptorReceptor Tyrosine Kinase	2010	52

Page 1